|
|
|
1-10 employees
View all
|
|
hospital & health care
|
|
815 NW 9th St,Corvallis,Oregon,US
|
|
Molybedum-99 (Mo-99) production is one the largest and most complex radiopharmaceutical undertakings in the United States (U.S.). Northwest Medical Isotopes, LLC (NWMI) is designing, licensing, constructing, and will operate a radioisotope production capability that will support target fabrication, recovery and purification of the Mo-99 product from irradiated low-enriched uranium (LEU) targets, and uranium recovery and recycle to produce Mo-99. In addition, NWMI is continuing to complete research and development (R&D) on the radioisotope production facility (RPF) technologies and will compete development and licensing of the required irradiation and transport systems necessary to support RPF operations. The challenges of the project go beyond size and complexity. The challenges to produce a reliable and sustainable Mo-99 capacity include maintaining a long-term commitment to selected technologies, and the logical, step-by-step demonstration and safe application of those technologies to produce Mo-99 in the NWMI RPF on a weekly basis.
|
Northwest Medical Isotopes, LLC Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Northwest Medical Isotopes, LLC email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Northwest Medical Isotopes, LLC customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.